batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Amgen’s Lumakras gets its colorectal date 7 August 2024 Pharmacosmos grants G1 a reprieve 7 August 2024 Merck and Daiichi team up again 6 August 2024 Agenus mulls a solo TIGIT path 5 August 2024 In Secura’s hands PI3K delta lives on 5 August 2024 FibroGen finally walks away from pamrevlumab 31 July 2024 Boehringer takes on AbbVie in a novel checkpoint 30 July 2024 Incyte swings the axe on oral checkpoint inhibitors 30 July 2024 Load More